Shaanxi Panlong Pharmaceutical (SZ:002864) Xin Lang Cai Jing·2025-10-28 01:19Group 1 - Panlong Pharmaceutical (002864.SZ) released its Q3 2025 report on October 28, 2025, indicating that as of October 27, 2025, eight institutional investors disclosed holdings in the company, totaling 4.95 million shares, which represents 4.66% of the total share capital [1] - The institutional investors include various funds and investment management companies, with a total institutional holding percentage increasing by 0.93 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one public fund, Huatai-PineBridge CSI Traditional Chinese Medicine ETF, increased its holdings by 0.12% compared to the previous period [2] - Two new public funds disclosed their holdings this quarter, including Changxin Jinli Trend Mixed A and Rongtong Health Industry Flexible Allocation Mixed A/B, while 44 public funds were not disclosed compared to the previous quarter [2]